Journal article

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial

BH Burmeister, BM Smithers, V Gebski, L Fitzgerald, RJ Simes, P Devitt, S Ackland, DC Gotley, D Joseph, J Millar, J North, ET Walpole, JW Denham

LANCET ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2005

Abstract

BACKGROUND: Resection remains the best treatment for carcinoma of the oesophagus in terms of local control, but local recurrence and distant metastasis remain an issue after surgery. We aimed to assess whether a short preoperative chemoradiotherapy regimen improves outcomes for patients with resectable oesophageal cancer. METHODS: 128 patients were randomly assigned to surgery alone and 128 patients to surgery after 80 mg/m(2) cisplatin on day 1, 800 mg/m(2) fluorouracil on days 1-4, with concurrent radiotherapy of 35 Gy given in 15 fractions. The primary endpoint was progression-free survival. Secondary endpoints were overall survival, tumour response, toxic effects, patterns of failure, an..

View full abstract